MaxCyte, Inc.
USD1.21
-0.04 (-2.82%)
CEO
Maher Masoud
IPO Date
2021-07-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.26
Prev. Close
$1.24
Day Low
$1.20
Day High
$1.26
52W Low
$0.64
52W High
$2.37
Market Cap
$0.13B
Volume
0.43M
| -10.6 |
| 31 Dec 2023 | FY | 88.5% | -91.8% | -16.3% | -14.1% | 0.08 | 10.65 | -12.8 |
| 31 Dec 2022 | FY | 88.5% | -53.3% | -9.3% | -8.2% | 0.06 | 16.35 | -23.6 |
| 31 Dec 2021 | FY | 89.2% | -56.3% | -7.3% | -6.7% | 0.02 | 17.32 | -48.4 |
| 31 Dec 2020 | FY | 89.4% | -45.2% | -35.6% | -22.8% | 0.21 | 3.90 | -99.9 |
| 31 Dec 2019 | FY | 88.4% | -59.6% | -94.8% | -43.0% | 0.53 | 2.62 | -74.4 |
| 31 Dec 2018 | FY | 89.0% | -53.2% | -72.2% | -36.5% | 0.41 | 3.42 | -98.1 |
| 31 Dec 2017 | FY | 89.6% | -70.9% | -50.6% | -31.6% | 0.26 | 4.22 | -83.4 |
| 31 Dec 2016 | FY | 89.3% | -27.3% | -65.8% | -20.8% | 0.98 | 2.79 | -170.3 |
| -4.3 |
| 30 Sept 2025 | Q3 | 92.4% | -181.8% | -6.9% | -5.8% | 0.10 | 7.74 | -3.4 |
| 30 Jun 2025 | Q2 | 82.1% | -145.3% | -6.5% | -5.6% | 0.10 | 12.39 | -4.7 |
| 31 Mar 2025 | Q1 | 85.6% | -98.8% | -5.1% | -4.5% | 0.09 | 12.23 | -7.0 |
| 31 Dec 2024 | Q4 | 73.8% | -121.9% | -5.1% | -4.4% | 0.09 | 10.88 | -10.3 |
| 30 Sept 2024 | Q3 | 76.4% | -141.6% | -5.4% | -4.6% | 0.09 | 9.81 | -8.8 |
| 30 Jun 2024 | Q2 | 85.7% | -89.9% | -4.2% | -3.7% | 0.08 | 14.31 | -10.7 |
| 31 Mar 2024 | Q1 | 87.6% | -84.0% | -4.2% | -3.7% | 0.08 | 13.26 | -11.4 |
| 31 Dec 2023 | Q4 | 90.0% | -33.7% | -2.3% | -2.0% | 0.08 | 10.65 | -23.1 |